Shin‐ya Tamechika

Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research

Shinji Maeda, Satoshi Osaga, Tomoyo Maeda et al. · PLoS ONE · 2019 · 25 citations · Full text

Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study

Shin‐ichiro Ohmura, Taio Naniwa, Shin‐ya Tamechika et al. · Journal of Infection and Chemotherapy · 2019 · 20 citations

Rheumatology, Pneumocystis Jirovecii Pneumonia, Systemic Rheumatic Diseases +8

Successful use of short-term add-on tocilizumab for refractory adult-onset still’s disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide

Shin‐ichiro Ohmura, Koji Uehara, Toru Yamabe et al. · Modern Rheumatology Case Reports · 2020 · 20 citations

Clinical Immunology, Macrophage Activation, Immunology +22

Short-term add-on tocilizumab and intravenous cyclophosphamide exhibited a remission-inducing effect in a patient with systemic lupus erythematosus with refractory multiorgan involvements including massive pericarditis and glomerulonephritis

Atsuko Iwai, Taio Naniwa, Shin‐ya Tamechika et al. · Modern Rheumatology · 2014 · 17 citations · Full text

Vasculitis, Immunology, Pathology +20

Coexistence of anti-melanoma differentiation-associated gene 5 and anti-aminoacyl-transfer RNA synthetase antibodies in a patient with dermatomyositis and rapidly progressive and relapsing interstitial lung disease

Taio Naniwa, Shin‐ya Tamechika, Yuka Okazaki et al. · Modern Rheumatology Case Reports · 2017 · 15 citations